Physician profile
Eric Alcaraz
NPI 1588614093
$4,467.13
in general payments reported to CMS, 2019-2025
27 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,992 · 2020: $559 · 2021: $512 · 2022: $320 · 2023: $192 · 2024: $587 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794 · Travel and Lodging: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.71 |
| Travel and Lodging | $289.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,566.00 | 2019-2023 | |
| Abbott Laboratories | $513.70 | 2020-2025 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $419.63 | 2019-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $287.89 | 2019-2021 | |
| Saluda Medical Americas, INC. | $262.91 | 2024 | Evoke |
| Daiichi Sankyo INC. | $252.68 | 2019 | |
| Painteq LLC | $242.43 | 2024 | Painteq |
| Scilex Pharmaceuticals INC. | $149.53 | 2019-2023 | Ztlido |
| Merz North America, INC. | $138.69 | 2019 | |
| Arbor Pharmaceuticals, INC. | $95.33 | 2021-2022 | |
| Forte Bio-Pharma LLC | $71.30 | 2022-2023 | Prolate, Nalocet |
| Medtronic USA, INC. | $68.86 | 2020 | |
| Biodelivery Sciences International, INC. | $67.73 | 2021 | |
| Redhill Biopharma INC. | $46.80 | 2020-2021 | |
| Horizon Therapeutics Plc | $37.88 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $37.41 | 2020-2021 | |
| Abbvie INC. | $28.58 | 2023 | Botox |
| Biohaven Pharmaceuticals, INC. | $24.30 | 2020 | |
| Assertio Therapeutics, INC. | $23.82 | 2019 | |
| Amgen INC. | $23.16 | 2021-2022 | |
| Allergan, INC. | $20.59 | 2021 | |
| Spr Therapeutics, INC | $18.05 | 2024 | Sprint Pns System |
| Vertos Medical, INC. | $17.81 | 2024 | Mild Device Kit |
| Ibsa Pharma INC. | $14.07 | 2023 | Tirosint, Licart |
| Pacira Cryotech Incorporated | $13.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.30 | 2020 | |
| Depuy Synthes Sales INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Alcaraz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.